Amyloid was then subclassified by immunohistochemistry. LCDD was diagnosed if renal biopsy showed non– Congophilic, light chain–restricted deposits that were granular by electron microscopy.

Previously known as primary amyloidosis, systemic amyloid light chain (AL) amyloidosis is the ... This type is an autosomal dominant disease in which the genetically inherited variant form of ...

[Kittleson 2020;1a] Thus, a number of distinct disease entities are ... can affect the heart include: Amyloid light-chain (AL) amyloidosis (also known as primary amyloidosis), caused by ...

Janssen has filed a new formulation of its Darzalex in the US for the rare and potentially fatal disease light chain (AL) amyloidosis ... to VCd alone and met its primary endpoint of overall ...

There are two main types of cardiac amyloidosis: light chain amyloidosis and transthyretin ... your healthcare team (which may include your primary care provider and cardiologist) can help you ...

This study sought to develop selection guidelines to determine the eligibility for SCT of patients with light-chain amyloidosis. Patients with biopsy-confirmed lightchain amyloidosis who underwent ...

The FDA granted Regenerative Medicine Advanced Therapy designation to NXC-201 for the treatment of relapsed/refractory light ...